Open Access Policy

Journal Policy

Pharmacological Horizons is an international peer-reviewed open-access journal committed to publishing high-quality, original, and impactful research in pharmacology, pharmaceutical sciences, clinical research, drug discovery, toxicology, biotechnology, and allied biomedical disciplines. The journal is dedicated to promoting scientific excellence, research integrity, innovation, and the global dissemination of scholarly knowledge.

Peer Review Policy

All manuscripts submitted to Pharmacological Horizons undergo a rigorous, transparent, and unbiased double-blind peer-review process designed to ensure scientific quality, originality, and ethical compliance.

Following submission, manuscripts are initially assessed by the Editorial Office to determine their suitability for the journal's scope, scientific merit, and adherence to submission requirements. Manuscripts that successfully pass the preliminary evaluation are assigned to independent expert reviewers with relevant subject expertise.

During the review process, both author and reviewer identities remain confidential to ensure an objective and impartial evaluation. Reviewers assess submissions based on originality, methodological quality, scientific significance, data integrity, ethical compliance, and clarity of presentation.

Based on reviewer recommendations and editorial assessment, manuscripts may be:

• Accepted for publication
• Accepted with minor revisions
• Returned for major revisions
• Rejected

The Editor-in-Chief retains final responsibility for publication decisions. Authors are expected to address reviewer comments thoroughly and submit revised manuscripts within the specified timeline.

Publication Ethics and Plagiarism Policy

Pharmacological Horizons adheres to the ethical principles and best practices established by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and other internationally recognized publishing standards.

Authors must ensure that submitted manuscripts represent original work that has not been previously published or simultaneously submitted to another journal. Proper acknowledgment and citation must be provided for all sources of information, data, figures, tables, and copyrighted materials.

All submitted manuscripts are screened using plagiarism detection software before entering the peer-review process. The journal maintains a strict zero-tolerance policy toward:

• Plagiarism
• Self-plagiarism
• Duplicate publication
• Data fabrication
• Data falsification
• Image manipulation
• Citation manipulation
• Unethical research practices

Authors are responsible for obtaining all necessary ethical approvals, permissions, informed consent documentation, and regulatory clearances where applicable. Any financial support, conflicts of interest, or funding sources must be disclosed during submission.

Research involving human participants or animals must comply with recognized ethical guidelines and include appropriate ethics committee approval statements.

The journal reserves the right to investigate allegations of misconduct at any stage of the editorial or publication process. Where ethical violations are confirmed, appropriate actions may include manuscript rejection, publication of corrections, expressions of concern, article retraction, or notification of relevant institutions.

Commitment to Research Integrity

Pharmacological Horizons is committed to maintaining fairness, transparency, accountability, and academic integrity throughout the publication process. The journal supports responsible research practices and strives to provide a trusted platform for the dissemination of scientifically rigorous and ethically conducted research that advances healthcare and biomedical knowledge worldwide.